Evidence map›Paper›PMID 36830664›Full record

ArticleBiomolecules2023

Bacterial Quorum-Sensing Peptides as Immune Modulators Present in Systemic Circulation.

Anton De Spiegeleer, Amélie Descamps, Srinath Govindarajan, Julie Coudenys, Kevin Van der Borght, Hannah Hirmz, Nele Van Den Noortgate, Dirk Elewaut, Bart De Spiegeleer, Evelien Wynendaele

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Streptococcal peptides and their roles in host-microbe interactions.Frontiers in cellular and infection microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Anton De SpiegeleerTranslational Research in Immunosenescence, Gerontology and Geriatrics (TRIGG) Group, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0002-3681-2807
Amélie DescampsTranslational Research in Immunosenescence, Gerontology and Geriatrics (TRIGG) Group, Ghent University, 9000 Ghent, Belgium.
Srinath GovindarajanVIB Inflammation Research Center, Unit for Molecular Immunology and Inflammation, Ghent University, 9000 Ghent, Belgium.
Julie CoudenysTranslational Research in Immunosenescence, Gerontology and Geriatrics (TRIGG) Group, Ghent University, 9000 Ghent, Belgium.
Kevin Van der BorghtDrug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0002-5233-4657
Hannah HirmzDrug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium.
Nele Van Den NoortgateTranslational Research in Immunosenescence, Gerontology and Geriatrics (TRIGG) Group, Ghent University, 9000 Ghent, Belgium.
Dirk ElewautTranslational Research in Immunosenescence, Gerontology and Geriatrics (TRIGG) Group, Ghent University, 9000 Ghent, Belgium.
Bart De SpiegeleerTranslational Research in Immunosenescence, Gerontology and Geriatrics (TRIGG) Group, Ghent University, 9000 Ghent, Belgium.
Evelien WynendaeleTranslational Research in Immunosenescence, Gerontology and Geriatrics (TRIGG) Group, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0003-0969-7580
Ghent University · BEGhent University Hospital · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quorum-sensing peptides (QSPs) are bacterial peptides traditionally considered only as inter-bacterial communication molecules. Recently, their involvement in microbiome-host interactions influencing host diseases such as cancer and sarcopenia were explored. However, it is still unknown to what extent these peptides have the potential to modulate the immune system. In this proof-of-concept study, we screened 89 QSPs for their potential to induce IL-6 and TNFα in murine splenocytes and J774 macrophages. Confirmatory experiments on the positive screening-hits were conducted using murine splenocytes and human PBMCs of different ages. Finally, to investigate the biological relevance of immunomodulatory QSPs, we analysed plasma in a human cohort for the presence of the immunomodulatory QSP Q010. To do this, we used a newly developed UHPLC-MS/MS method. Our findings indicated that specific QSPs activate immune cells in vitro, with Q007, Q010, Q017 and Q212 being the top four screening hits. Q007 and Q010 were affirmed in subsequent confirmatory experiments using murine splenocytes and human PBMCs. Finally, Q010 was detected in human plasma, demonstrating for the first time the presence of an immunomodulatory QSP in human circulation. In conclusion, our data are the first evidence indicating the potential of biologically relevant quorum-sensing peptides to modulate the immune system.

Indexed as

PeptidesTandem Mass SpectrometryAnimalsBacteriaHumansImmunologic FactorsMiceQuorum SensingImmunologic FactorsPeptidesimmune cellsJ774microbiomePBMCquorum-sensing peptidessplenocytes

Identifiers

PMID36830664
PMCPMC9953703
OpenAlexW4319316563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.